Description: Guanhao Biotech Co.,Ltd. develops, manufactures, and markets regenerative medicine in China. It offers NormalGEN, a type of biological dura repair patch manufactured from animal tissue; GrandNeuro, an artificial dura patch for dura repairing; ThormalGEN, a biological surgical patch manufactured from animal tissue for surgical repairs; DermalGEN, a wound dressing product manufactured from animal tissue for use on burns, scalds, and wounds due to skin loss or trauma; and IREAL breast patch. The company was founded in 1999 and is based in Guangzhou, China.
Home Page: www.guanhaobio.com
No. 12 Yuyan Road
Guangzhou,
510530
China
Phone:
86 20 3205 2806
Officers
| Name | Title |
|---|---|
| Mr. Bin Xu | CEO, Vice-Director of National Engineering Laboratory & Non-Independent Director |
| Prof. Guofeng Xu | Chief Technology Officer |
| Mr. Minjie Hu | Chief Scientist of Cell and Stem Cell Research |
Exchange: SHE
Country: CN
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 39.4231 |
| Price-to-Book MRQ: | 5.385 |
| Price-to-Sales TTM: | 6.0512 |
| IPO Date: | 2011-07-06 |
| Fiscal Year End: | December |
| Full Time Employees: | 503 |